Yat Sun Or
2011
In 2011, Yat Sun Or earned a total compensation of $503.8K as Senior Vice President, Research Development and Chief Scientific Officer at Enanta Pharmaceuticals.
Compensation breakdown
| Bonus | $105,519 |
|---|---|
| Option Awards | $80,679 |
| Salary | $313,208 |
| Other | $4,421 |
| Total | $503,826 |
Or received $313.2K in salary, accounting for 62% of the total pay in 2011.
Or also received $105.5K in bonus, $80.7K in option awards and $4.4K in other compensation.
Rankings
In 2011, Yat Sun Or's compensation ranked 8,014th out of 10,747 executives tracked by ExecPay. In other words, Or earned more than 25.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,014 out of 10,747 | 25th |
Division Manufacturing | 2,942 out of 3,958 | 26th |
Major group Chemicals And Allied Products | 731 out of 1,031 | 29th |
Industry group Drugs | 522 out of 779 | 33rd |
Industry Pharmaceutical Preparations | 402 out of 567 | 29th |
Source: SEC filing on January 10, 2014.
Or's colleagues
We found two more compensation records of executives who worked with Yat Sun Or at Enanta Pharmaceuticals in 2011.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019